MindMed is a clinical-stage biopharmaceutical company developing novel products to treat brain health disorders, with a particular focus on psychiatry, addiction, pain and neurology. Our mission is to be the global leader in the development and delivery of treatments that unlock new opportunities to improve patient outcomes. We are developing a pipeline of innovative drug candidates, with and without acute perceptual effects, targeting the serotonin, dopamine and acetylcholine systems. MindMed trades on the NASDAQ under the symbol MNMD and on the Canadian NEO Exchange under the symbol MMED.
View Top Employees from MindMed| Website | http://www.mindmed.co |
| Revenue | $4 million |
| Funding | $91.9 million |
| Employees | 89 (79 on RocketReach) |
| Founded | 2019 |
| Address | One World Trade Center, Suite 8500, New York, New York 10007, US |
| Phone | (650) 208-2454 |
| Technologies |
JavaScript,
HTML,
PHP
+34 more
(view full list)
|
| Industry | Biotechnology Research, Pharmaceuticals, Health Care, Drug Discovery, Healthcare |
| SIC | SIC Code 28 Companies, SIC Code 283 Companies |
| NAICS | NAICS Code 3254 Companies, NAICS Code 32541 Companies, NAICS Code 32 Companies, NAICS Code 325 Companies |
Looking for a particular MindMed employee's phone or email?
MindMed Questions
The MindMed annual revenue was $4 million in 2024.
Dan Karlin is the Chief Medical Officer of MindMed.
79 people are employed at MindMed.
MindMed is based in New York, New York.
The NAICS codes for MindMed are [3254, 32541, 32, 325].
The SIC codes for MindMed are [28, 283].
Top MindMed Employees
-
55+
-
5+5+
-
35+
-
25+
-
22
-
44
-
35+
Related Companies
